Cyclacel Pharmaceuticals Inc (CYCC)
1.83
+0.08
(+4.57%)
USD |
NASDAQ |
Apr 23, 16:00
1.79
-0.04
(-2.19%)
Pre-Market: 08:09
Cyclacel Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2011 | 57.14% |
| March 31, 2011 | 44.79% |
| December 31, 2010 | 28.90% |
| September 30, 2010 | 52.20% |
| June 30, 2010 | 22.69% |
| March 31, 2010 | 47.60% |
| December 31, 2009 | 60.96% |
| Date | Value |
|---|---|
| September 30, 2009 | 29.13% |
| June 30, 2009 | 27.82% |
| March 31, 2009 | 49.12% |
| December 31, 2008 | 54.58% |
| September 30, 2008 | 55.39% |
| June 30, 2008 | 45.00% |
| March 31, 2008 | 45.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -227.3% |
| Return on Assets | -128.4% |
| Return on Invested Capital | -227.3% |
| Profit Margin (Quarterly) | -17.00K% |
| Operating Margin (Quarterly) | -17.29K% |
| Return on Net Operating Assets | -279.9% |